Products - Heart failure | Topic | NICE

Showing 8 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Chronic heart failure in adults: diagnosis and management - Pharmacological treatment of chronic heart failure
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 September 2025
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults
Status:
In development | In consultation
Programme:
Interventional procedures guidance
Consultation end date:
21 May 2025
Expected publication date:
11 September 2025
⁠Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adults
Status:
In development | In consultation
Programme:
Interventional procedures guidance
Consultation end date:
21 May 2025
Expected publication date:
11 September 2025
Digital platforms to support cardiac rehabilitation: early value assessment
Status:
In development
Programme:
Health technology evaluation
Expected publication date:
18 November 2025
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure
Status:
In development
Programme:
Diagnostics guidance
Expected publication date:
20 January 2026
Insertion of a catheter-based intravascular microaxial flow pump for cardiogenic shock
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
11 March 2026
Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Finerenone for treating heart failure with preserved or mildly reduced ejection fraction ID6514
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC